2.18 Questions of the Week, Talking About Toxicity, ASCO Guidelines Authors' COI with Dr. Eitan Amir

Plenary Session

Vinay Prasad, MD MPH

Medicine, Policy, Health, Science & Medicine, Oncology

4.8 • 799 Ratings

🗓️ 18 October 2019

⏱️ 77 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

This week we begin with a critique of the recent perspective article in the New England Journal of Medicine, titled "Talking about Toxicity — 'What We’ve Got Here Is a Failure to Communicate'". After that we interview Dr. Eitan Amir on his paper on undisclosed conflicts of interest among authors of ASCO guidelines. Interspersed between segments of the interview, we invite guest Dr. Sven Olson on to offer a correction to a recent Hem/Onc boards question of the week on Lynch Syndrome (original question posed in episode 2.11) and we invite Ian Straehley on for a question of the week inspired by the USMLE Step 2 CK. Talking about toxicity: doi.org/10.1056/NEJMp1908310 COI among authors of ASCO guidelines: doi.org/10.1002/cncr.32408 Transparency in medicine: doi.org/10.1002/cncr.32407 Back us on Patreon! www.patreon.com/plenarysession

Transcript

Click on a timestamp to play from that location

0:00.0	Welcome to Plenary Session.
0:07.0	I'm your host, Dr. Vinay Prasad.
0:10.0	I'm a practicing hematologist, oncologist, and I'm associate professor of medicine.
0:14.0	I'm interested in issues at the intersection of medicine, oncology, and health policy, and that's what you're going to get on this podcast.
0:22.2	Welcome to Season 2.
0:24.9	This week on Plenary Session, we have a few things for you.
0:28.1	We have question of the week, because how could you go a week without it?
0:31.0	We also have special guests joining us from the Princess Margaret Hospital in Toronto, Canada, Aton Amir,
0:36.7	and he's going to talk about a new
0:38.5	paper revealing disclosed and undisclosed financial conflict of interest. But first, we're
0:44.1	going to talk about talking about toxicity. What we've got here is a failure to communicate.
0:49.9	This is in the New England Journal of Medicine. It's a perspective by Dr. Sachs, Miller, and Dr. Dan Longo.
0:56.2	He's back.
0:57.5	Little old Dan Longo's got another editorial in the New England Journal of Medicine,
1:00.9	and you won't want to miss this discussion about talking about toxicity.
1:05.4	We're going to be talking about the article talking about toxicity,
1:08.6	and you won't want to miss this on Plenary Session.
1:12.9	But first, a thanks. I want to thank those of you who've gone online and support this
1:17.7	podcast on Patreon.com. Patreon subscribers get access to the slides from lectures I give on Plenary
1:23.5	Session. I also want to thank the hundreds of you who've gone to the iTunes store and reviewed this podcast. We appreciate that feedback. I also want to thank the hundreds of you who've gone to the iTunes store
1:27.6	and reviewed this podcast. We appreciate that feedback. I also want to thank the dozens of you
1:32.9	who've written reviews. A written review goes a long way. What can plenary session do for you?
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from Vinay Prasad, MD MPH, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Vinay Prasad, MD MPH and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.